Physician profile
William Whang
NPI 1972586964
$3,853.87
in general payments reported to CMS, 2019-2025
11 companies · $517 in 2025
The $517 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $629 · 2020: $81.19 · 2021: $56.20 · 2022: $632 · 2023: $250 · 2024: $1,689 · 2025: $517.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,444 · Travel and Lodging: $1,012.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,443.82 |
| Travel and Lodging | $1,011.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,336.25 | 2019-2025 | Aveir, Ensite, Perclose Prostyle |
| Boston Scientific Corporation | $1,204.66 | 2019-2025 | Lux-Dx Insertable Cardiac Monitor, Farapulse |
| Cardiva Medical, INC. | $643.49 | 2019-2023 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade 5f Vcs |
| Medtronic, INC. | $194.99 | 2024-2025 | Micra |
| E.R. Squibb & Sons, L.L.C. | $171.99 | 2022-2025 | Camzyos |
| Biosense Webster, INC. | $138.93 | 2024 | Carto 3 |
| Cordis US Corp. | $72.46 | 2023-2025 | Mynx Control, Mynx Control Venous |
| Atricure, INC. | $47.05 | 2024-2025 | Epi-Sense Guided Coagulation System With Visitrax, Epi-Ease Epicardial Access System, Atriclip Laa Exclusion System |
| Irhythm Technologies, INC. | $44.05 | 2024 | Zio Monitor, Zio Xt Patch |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Whang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.